


KSL | Pulse Scientific Revenue
Biotechnology Research • Burlington, Ontario, Canada • 1-10 Employees
KSL | Pulse Scientific revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at KSL | Pulse Scientific
Puja Chopra
Director of Quality Assurance
Company overview
| Headquarters | 5100 South Service Road, Unit 18, Burlington, Ontario L7L 6A5, CA |
| Phone number | +18003637907 |
| Website | |
| NAICS | 541714 |
| SIC | 504 |
| Keywords | Research, Quality Control, Medical Devices, Microbiology, Biotech, Fertility, Laboratory, Serology, Infant Screening |
| Founded | 1992 |
| Employees | 1-10 |
| Socials |
About KSL | Pulse Scientific
Pulse Scientific/ KSL Biomedical KSL Biomedical, Inc., developers of novel diagnostic and therapeutic applications for immunology, oncology, virology, and genomics, announces expansion into Canada with the acquisition of Pulse Scientific, Inc. a diagnostic products manufacturer and distributor of medical, laboratory and research products located in Toronto. With the incorporation of KSL Biomedical Canada, Inc., and the acquisition of Pulse Scientific, KSL extends its international base for product distribution and laboratory sales, positioning the company to merge additional technology, business lines, and acquisition targets in Burlington, the Greater Toronto Area (GTA), and beyond. Pulse Scientific established in 1992, specializes in the manufacturing and distribution of technical microbiology products and controls for clinical, industrial, and pharma customers, as well as in vitro diagnostic (IVD) tests for laboratories and physicians. The company is ISO 13485 certified and licensed by Health Canada, positioning it to distribute medical devices and in vitro diagnostics in Canada, Europe, and many other markets throughout the world. “Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them. We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team,” said Kevin Lawson, President and CEO of KSL Biomedical. Presenting a number of synergistic opportunities, the acquisition allows KSL to add proprietary products and services to its pipeline, including exclusive diagnostics, laboratory products, medical devices, and assays, utilizing proprietary biomarkers and instrumentation.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
KSL | Pulse Scientific has never raised funding before.
KSL | Pulse Scientific Tech Stack
Discover the technologies and tools that power KSL | Pulse Scientific's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Tag managers
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
Analytics
Frequently asked questions
4.8
40,000 users



